Followers | 1326 |
Posts | 248,914 |
Boards Moderated | 60 |
Alias Born | 12/07/2009 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$AVRW .0498 +10.67% New Interview Nancy Duitch, CEO Avenir Wellness Solutions With over three decades of experience in the consumer products sector, Nancy has cultivated a diverse array of businesses, guiding them from inception to the public market
$AVRW .0498 +10.67% New Interview Nancy Duitch, CEO Avenir Wellness Solutions With over three decades of experience in the consumer products sector, Nancy has cultivated a diverse array of businesses, guiding them from inception to the public market
$CATV bouncing off lows, longs accumulating shares. #bullish
$CBDW .049 +2.08% HOD .055 another accumulation day for this #AIEnhanced #OTC Ran to .10 last week! @CBDWInc #Nasdaq CEO Austen Lambrecht www.cbdw.ai
$CBDW .049 +2.08% HOD .055 another accumulation day for this #AIEnhanced #OTC Ran to .10 last week! @CBDWInc #Nasdaq CEO Austen Lambrecht www.cbdw.ai
$ILUS $QIND recently acquired a 51% interest in Al Shola Gas, which delivered nearly $11 million in revenue and $1.8 million in net income in 2023. #UPLIST $ASNS https://www.wsj.com/articles/ilus-moves-forward-with-its-two-subsidiary-uplists-and-equity-dividend-068001b1?reflink=mw_share_twitter
$ILUS $QIND recently acquired a 51% interest in Al Shola Gas, which delivered nearly $11 million in revenue and $1.8 million in net income in 2023. #UPLIST $ASNS https://www.wsj.com/articles/ilus-moves-forward-with-its-two-subsidiary-uplists-and-equity-dividend-068001b1?reflink=mw_share_twitter
$EPAZ is advancing in battery technology for high-powered devices and aircraft. With patents underway, #GalaxyBatteries aims to revolutionize energy storage, eyeing independence. Focusing on efficiency and innovation! #Epazz #BatteryTech #Innovation #GreenEnergy
$EPAZ is advancing in battery technology for high-powered devices and aircraft. With patents underway, #GalaxyBatteries aims to revolutionize energy storage, eyeing independence. Focusing on efficiency and innovation! #Epazz #BatteryTech #Innovation #GreenEnergy pic.twitter.com/DFYKd8kyGT
— Epazz, Inc. Ticker: $EPAZ (@epazz) May 21, 2024
$EPAZ is advancing in battery technology for high-powered devices and aircraft. With patents underway, #GalaxyBatteries aims to revolutionize energy storage, eyeing independence. Focusing on efficiency and innovation! #Epazz #BatteryTech #Innovation #GreenEnergy
$EPAZ is advancing in battery technology for high-powered devices and aircraft. With patents underway, #GalaxyBatteries aims to revolutionize energy storage, eyeing independence. Focusing on efficiency and innovation! #Epazz #BatteryTech #Innovation #GreenEnergy pic.twitter.com/DFYKd8kyGT
— Epazz, Inc. Ticker: $EPAZ (@epazz) May 21, 2024
$CYCA CEO Gary Campbell discusses updates on development of IGAN 2.0 and future of Cytta Corp
$CYCA CEO Gary Campbell discusses updates on development of IGAN 2.0 and future of Cytta Corp
$CBDW BUY Opinion on @Barchart #Bullish Outlook
https://www.barchart.com/stocks/quotes/CBDW/opinion @CBDWInc @MrSamuelPowers #IRChat #chatCBDW
$META $COIN $DEC $SRTY $PSCC $USB $SOXL $AMD $KR $JCI $HAL $SOFI $MU $JD $APO $DOCN $JNJ $MDB $LYB $WWD $DUK $DJT $XLK $CB $BLK
$CBDW BUY Opinion on @Barchart #Bullish Outlook
https://www.barchart.com/stocks/quotes/CBDW/opinion @CBDWInc @MrSamuelPowers #IRChat #chatCBDW
$META $COIN $DEC $SRTY $PSCC $USB $SOXL $AMD $KR $JCI $HAL $SOFI $MU $JD $APO $DOCN $JNJ $MDB $LYB $WWD $DUK $DJT $XLK $CB $BLK
$CBDW Weekly Stock Analysis and Innovation Spotlight: 1606 Corp (CBDW) https://allcapresearch.com/f/weekly-stock-analysis-and-innovation-spotlight-1606-corp-cbdw via @ResearchAllcap @CBDWInc
$CBDW Weekly Stock Analysis and Innovation Spotlight: 1606 Corp (CBDW) https://allcapresearch.com/f/weekly-stock-analysis-and-innovation-spotlight-1606-corp-cbdw via @ResearchAllcap @CBDWInc
$AVRW Solid Growth Reported for Seratopical Revolutions Skin Care Line with Boost from Famed Beauty Box FabFitFun and Endorsements from Key Celebrities, Influencers and Top Medical Professionals: Avenir Wellness Solutions, Inc. (Stock Symbol: AVRW) https://www.einpresswire.com/article/711238053/solid-growth-for-seratopical-revolutions-skin-care-line-boost-from-famed-fabfitfun-many-key-celebrities-otc-avrw
$AVRW Solid Growth Reported for Seratopical Revolutions Skin Care Line with Boost from Famed Beauty Box FabFitFun and Endorsements from Key Celebrities, Influencers and Top Medical Professionals: Avenir Wellness Solutions, Inc. (Stock Symbol: AVRW) https://www.einpresswire.com/article/711238053/solid-growth-for-seratopical-revolutions-skin-care-line-boost-from-famed-fabfitfun-many-key-celebrities-otc-avrw
$IVDN Low Float of 16 million is on track for a record sales and revenue growth year in 2024, as detailed in official company news below. IVDN management is making steady progress to grow market share and also protect the very valuable patent rights of its unique Insultex product line which is the only evacuated cell insulation on the market with energy saving performance that no competitor can match.
IVDN is now starting to see accelerating sales success as word is spreading about Insultex House Wrap as described on the dedicated website at http://www.insultexhousewrap.com. Add to this advantage, the fact that the IVDN product meets or exceeds new building codes going into effect this year requiring continuous insulation while competitors are failing this critical criteria. www.InsultexHouseWrap.com
Innovative Designs Vendor Growth
https://finance.yahoo.com/news/innovative-designs-vendor-growth-174255528.html
$IVDN Low Float of 16 million is on track for a record sales and revenue growth year in 2024, as detailed in official company news below. IVDN management is making steady progress to grow market share and also protect the very valuable patent rights of its unique Insultex product line which is the only evacuated cell insulation on the market with energy saving performance that no competitor can match.
IVDN is now starting to see accelerating sales success as word is spreading about Insultex House Wrap as described on the dedicated website at http://www.insultexhousewrap.com. Add to this advantage, the fact that the IVDN product meets or exceeds new building codes going into effect this year requiring continuous insulation while competitors are failing this critical criteria. www.InsultexHouseWrap.com
Innovative Designs Vendor Growth
https://finance.yahoo.com/news/innovative-designs-vendor-growth-174255528.html
$CATV NEWS OUT: Category V Biotech, Inc. Announces Exclusive Licensing of Genetic Networks' Intellectual Property for Cannabis Applications
FLORIDA, July 2, 2024 – Category V Biotech, Inc. (OTC: CATV), formerly known as 4Cable TV International, Inc., is pleased to announce significant progress in our relationship with Genetic Networks, LLC (https://geneticnetworks.com/).
https://www.otcmarkets.com/stock/CATV/news/CATV-signs-Exclusive-Licensing-Deal-with-Genetic-Networks-for-Cannabis-Research?id=445565
$CATV NEWS: Category V Biotech, Inc. Announces Exclusive Licensing of Genetic Networks' Intellectual Property for Cannabis Applications
FLORIDA, July 2, 2024 – Category V Biotech, Inc. (OTC: CATV), formerly known as 4Cable TV International, Inc., is pleased to announce significant progress in our relationship with Genetic Networks, LLC (https://geneticnetworks.com/).
https://www.otcmarkets.com/stock/CATV/news/CATV-signs-Exclusive-Licensing-Deal-with-Genetic-Networks-for-Cannabis-Research?id=445565
$CATV NEWS: Category V Biotech, Inc. Announces Exclusive Licensing of Genetic Networks' Intellectual Property for Cannabis Applications
FLORIDA, July 2, 2024 – Category V Biotech, Inc. (OTC: CATV), formerly known as 4Cable TV International, Inc., is pleased to announce significant progress in our relationship with Genetic Networks, LLC (https://geneticnetworks.com/).
While continuing to analyze the acquisition, Category V Biotech and Genetic Networks have agreed to allow CATV to become the exclusive licensee of all Genetic Networks’ intellectual property and technology worldwide for cannabis applications. This agreement allows Genetic Networks time to address internal matters found during due diligence, while Category V Biotech begins its journey into the discovery of medicines using cannabis. This licensing agreement will facilitate close collaboration with Genetic Networks on cannabis research and development, positioning Category V Biotech as a leader in developing cannabis medicines.
Our goal is to screen cannabis and cannabis-derived products to determine their medicinal benefits by utilizing Genetic Networks' extensive disease database accumulated over the past decade while working for pharmaceutical companies and government. Discovering the use of cannabis for specific diseases is key to developing medicines that can be registered with regulatory bodies worldwide and distributed for medical use or treatment.
The exclusive licensing of Genetic Networks’ technologies, including their proprietary platform GeneScape™, will facilitate the rapid and unbiased discovery of optimal drug compounds from cannabis through whole-genome analysis. This exclusive license allows Category V Biotech to expand into the biotech sector of the cannabis industry, leveraging Genetic Networks' expertise in accelerating compound discovery and development for pre-clinical and clinical testing.
"We are excited to welcome Genetic Networks into the Category V Biotech family," stated Michael Feldenkrais, CEO of Category V Biotech. "Their state-of-the-art platform and extensive knowledge will be instrumental as we strive to unlock the full potential of cannabis-based therapeutics. Together, we anticipate bringing novel treatments to patients faster than ever before, as regulated FDA products under the new regulatory environment of the United States." Dr. Gennaro D’Urso, co-founder of Genetic Networks, echoed this enthusiasm, stating, "Category V Biotech shares our dedication to leveraging genetics to revolutionize drug development. By joining forces, we envisage broadening the reach and impact of our platform, ultimately delivering superior medicines to patients in need."
Upon resolving internal matters identified during due diligence, Category V Biotech will complete the acquisition of Genetic Networks. Following the transaction, Genetic Networks will operate as a wholly owned subsidiary of Category V Biotech, retaining its existing management team and facilities. Category V Biotech plans to leverage Genetic Networks' capabilities across its global cannabis operations, including cultivation, biotech research, and retail. This transaction culminates years of discussions, awaiting the right moment for research and development in the United States to create pharmaceutical-grade products using cannabis.
The recent changes in the rescheduling of cannabis from Controlled Substance I to Controlled Substance III, reflecting a change in U.S. policies, has paved the way for Category V Biotech and Genetic Networks to capitalize on emerging opportunities in the cannabis industry, driving innovation and advancing therapeutic solutions for patients. Category V Biotech remains actively engaged in pursuing additional acquisitions in the cannabis industry as part of its growth strategy, with further transactions expected to be announced in the coming months.
About Genetic Networks, LLC
Established in 2015, Genetic Networks, LLC has been at the forefront of serving three of the top ten bio-pharmaceutical companies with its GeneScape™ technology. GeneScape™ expedites drug asset development through applied molecular biology, offering a multidimensional map of diseases and drugs that integrates genome-wide functional assays of drug activity (H-Tech) and human genes and gene variants (Y-Tech) using proprietary analytics. Genetic Networks' GeneScape™ platform accelerates the discovery and development of optimal candidate compounds for pre-clinical and clinical testing, identifying the optimal intersection between targets and compounds in specific disease spaces through whole-genome genetic perturbation and analysis. About Category V Biotech, Inc. Category V Biotech, Inc. (OTC: CATV) aims to establish and operate a fully integrated global cannabis company, encompassing biotech research, cultivation, manufacturing, and retail. Through strategic acquisitions and organic growth, the company strives to emerge as the world's leading provider of pharmaceutical cannabis-based products and therapies.
Good morning $CATV
$AVRW Netflix #1 Movie "A Family Affair" with Nicole Kidman spokesperson for @AvenirWellness #celebrity #SeralabsHealth https://people.com/nicole-kidman-zac-efron-share-nsfw-original-title-new-romcom-exclusive-8670858 #OTCQB
$AVRW Netflix #1 Movie "A Family Affair" with Nicole Kidman spokesperson for @AvenirWellness #celebrity #SeralabsHealth https://people.com/nicole-kidman-zac-efron-share-nsfw-original-title-new-romcom-exclusive-8670858 #OTCQB
$CBDW .05 Up +13.77% from the dip as buyers grab onto this opportunity. Watching for more updates from
@CBDWInc on Twitter!
$CBDW .05 Up +13.77% from the dip as buyers grab onto this opportunity. Watching for more updates from
@CBDWInc on Twitter!
$CBDW 1606 Corp (CBDW): A Promising Breakout https://cbdw.ai/1606-corp-cbdw-a-promising-breakout/ @CBDWInc
$CBDW 1606 Corp (CBDW): A Promising Breakout https://cbdw.ai/1606-corp-cbdw-a-promising-breakout/ @CBDWInc
$META $COIN $DEC $SRTY $PSCC $USB $SOXL $AMD $KR $JCI $HAL $SOFI $MU $JD $APO $DOCN $JNJ $MDB $LYB $WWD $DUK $DJT $XLK $CB $BLK $TROW $MSTR $HIMS $META $AAPL $GOOGL $GOOG $GE
$CATV .0016 HOD .00175 #OTC #Mondaymover
$CATV .0016 HOD .00175 #OTC #Mondaymover
$CATV on Marketscreener #Undervalued #Trip Category V Biotech, Inc. Announces Letter of Intent to Acquire Genetic Networks, Expanding into Biotech Sector @catvbiotech
https://marketscreener.com/quote/stock/4CAE-TVIN0-13149234/news/Category-V-Biotech-Inc-Announces-Letter-of-Intent-to-Acquire-Genetic-Networks-Expanding-into-Biot-46734788/
$CATV on Marketscreener #Undervalued #Trip Category V Biotech, Inc. Announces Letter of Intent to Acquire Genetic Networks, Expanding into Biotech Sector
@catvbiotech
https://marketscreener.com/quote/stock/4CAE-TVIN0-13149234/news/Category-V-Biotech-Inc-Announces-Letter-of-Intent-to-Acquire-Genetic-Networks-Expanding-into-Biot-46734788/ $IGEX
$CYCA -Great Video Out! Every second counts during the darkest of times. That's why Cytta corp created CYTTA CARES (Crisis Alert and Response Emergency System) is an innovative software-as-a-service solution designed to enhance safety and security in educational institutions especially during emergency situations. This comprehensive system provides real-time alerts, rapid two-way secure video communication, and efficient response coordination, ensuring the well-being of students, staff, and faculty. With its user-friendly, simple interface, users can quickly initiate emergency notifications through designated app and other various channels like SMS, emails, and push notifications.
The system also enables two-way communication, allowing individuals to report incidents or request assistance instantly. Additionally, it provides live location tracking to emergency response teams, enabling better coordination and resource allocation. By leveraging technology, Cytta CARES empowers educational institutions to proactively address emergencies, mitigate risks, and safeguard their community effectively.
#firstresponders #Cytta #igan #police #dronemonitoring #safety #videostreaming #videocompression #commandcenter #schoolsecurity #schoolsafety, #investor, #earlystagetech #ai #Surveillance #Cyttacares #schoolsafety #schoolsecurity
$CYCA -Great Video Out! Every second counts during the darkest of times. That's why Cytta corp created CYTTA CARES (Crisis Alert and Response Emergency System) is an innovative software-as-a-service solution designed to enhance safety and security in educational institutions especially during emergency situations. This comprehensive system provides real-time alerts, rapid two-way secure video communication, and efficient response coordination, ensuring the well-being of students, staff, and faculty. With its user-friendly, simple interface, users can quickly initiate emergency notifications through designated app and other various channels like SMS, emails, and push notifications.
The system also enables two-way communication, allowing individuals to report incidents or request assistance instantly. Additionally, it provides live location tracking to emergency response teams, enabling better coordination and resource allocation. By leveraging technology, Cytta CARES empowers educational institutions to proactively address emergencies, mitigate risks, and safeguard their community effectively.
#firstresponders #Cytta #igan #police #dronemonitoring #safety #videostreaming #videocompression #commandcenter #schoolsecurity #schoolsafety, #investor, #earlystagetech #ai #Surveillance #Cyttacares #schoolsafety #schoolsecurity
$CYCA Investors can sign up for The Weekly Cytta Corp Newsletter & Webcast
https://cytta.com/investors/
$CYCA Stay Up to Date with The Weekly Cytta Corp Newsletter & Webcast
Sign up here: https://cytta.com/investors/
$CBDW #Bullish Stay tuned for more exciting things in the coming weeks. #AI #Chatbots #CBDW #OTC
http://cbdw.ai #ChatCBDW CEO Austen Lambrecht
$ATVK .0014 x .0015 +27.27% When these companies recover you will be long gone.
$CATV .0017 New HOD .0018 on ASK. Genetic Networks trading on the OTC. https://geneticnetworks.com/